arrow
M

Marie-Laure Golinski

univ rouen normandie
H指数:12
被引数:587

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anti-carbamylated fibrinogen autoantibodies of IgG and IgA isotypes contribute to a better prognostic stratification in very early rheumatoid arthritis: data from the French national ESPOIR cohort

IgG和IgA亚型的抗羧基化纤维蛋白原自身抗体有助于改善超早期类风湿关节炎的预后分层:法国国家ESPOIR队列研究数据

2026-07-280
OAAI
Persistence of anti-desmoglein 3 antibodies in patients with pemphigus vulgaris in complete remission is associated with restricted isotype diversity and desmoglein 3 ectodomain recognition

寻常型天疱疮患者完全缓解期抗-desmoglein 3 抗体的持续性与其亚型多样性受限和 desmoglein 3 胞外域识别有关

2026-05-010
PRE
Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris

利妥昔单抗在落叶型天疱疮患者中的长期疗效与安全性,并与寻常型天疱疮进行比较

2025-04-010
PRE
Prevalence and pathogenic activity of anti-desmocollin-3 antibodies in patients with pemphigus vulgaris and pemphigus foliaceus

抗-desmocollin-3抗体的流行率及致病活性:在寻常性天疱疮和落叶性天疱疮患者中的研究

2025-02-241
PRE
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy Follow-Up of the Ritux 3 Trial
2024-03-017
PRE
FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus

FcRn拮抗作用导致桥粒特异性b细胞减少: 寻常型天疱疮和落叶型天疱疮中Efgartigimod 2期研究的二次分析

2022-05-1824
OAAI
Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus

利妥昔单抗和皮质类固醇对天疱疮的桥粒特异性b细胞和桥粒特异性T滤泡辅助细胞的影响

2021-09-0122
OAAI
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy A Post Hoc Analysis of a Randomized Clinical Trial
2020-05-0143
OAAI
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect
2019-11-2868
OAAI